List of GLP-1 receptor agonists: difference between revisions
Diff·revision 7 → 8·12:19, 10 Nov 2024
Difference between revision 7 and revision 8 of List of GLP-1 receptor agonists. 9 lines changed; the page grew by 349 bytes.
| Revision 7 — 00:37, 16 Oct 2024 Chromatokid (talk) add the cross-link to the parent article 2,257 bytes ±0 | Revision 8 — 12:19, 10 Nov 2024 UnitsUrsula (talk) sort the list by the column the lead says it is sorted by 2,606 bytes +349 | ||
|---|---|---|---|
| 24 | The list spans three architectures: exendin-derived peptides, [[Albumin binding half-life extension|acylated]] GLP-1 analogues, an Fc fusion, and a non-peptide small molecule. See [[GLP-1 receptor agonist]] for how each solves the half-life problem.{{r|drucker2018}} | 24 | The list spans three architectures: exendin-derived peptides, [[Albumin binding half-life extension|acylated]] GLP-1 analogues, an Fc fusion, and a non-peptide small molecule. See [[GLP-1 receptor agonist]] for how each solves the half-life problem.{{r|drucker2018}} |
| 25 | 25 | ||
| + | 26 | == Multi-receptor agonists == | |
| + | 27 | | Compound | Receptors | Status | | |
| + | 28 | |---|---|---| | |
| + | 29 | | [[Tirzepatide]] | GIP, GLP-1 | Approved | | |
| + | 30 | | [[Survodutide]] | Glucagon, GLP-1 | Investigational | | |
| + | 31 | | [[Efinopegdutide]] | Glucagon, GLP-1 | Investigational | | |
| + | 32 | | Mazdutide | Glucagon, GLP-1 | Investigational | | |
| + | 33 | | [[Retatrutide]] | GIP, GLP-1, glucagon | Investigational | | |
| + | 34 | ||
| 26 | == References == | 35 | == References == |
| 27 | {{reflist}} | 36 | {{reflist}} |